The US Food and Drug Administration has approved another vaccine to help protect older people from respiratory syncytial ...

Learn about this vaccine that protects against a common seasonal virus that can sometimes cause severe disease, with info on ...

The world's first bivalent mRNA vaccine candidate against respiratory syncytial virus, or RSV, kicked off Phase I clinical ...

The trials for Moderna's mRESVIA vaccine, which uses the same mRNA technology as the company's Covid-19 shot, did not show ...

The CDC lowered the age for the pneumonia vaccination from 65 to 50 and recommended an extra COVID shot to some people.

COVID-19, influenza, and respiratory syncytial virus vaccination coverage is low among adults so far this respiratory virus season (2024 to 2025).

A new Centers for Disease Control and Prevention (CDC) report reveals low uptake of flu, COVID-19 and respiratory syncytial ...

GSK said on Friday that its respiratory syncytial virus (RSV) vaccine has received approval in Japan for expanded use in ...

A judge in the U.K. last month sided with Pfizer over GSK in a respiratory syncytial virus vaccine patent lawsuit, ...

RSV vaccination at least five weeks prior to delivery results in the highest transplacental transfer of maternal antibodies to the neonate.

Moderna and Merck have started exploring a Phase 3 trial of combining mRNA-4157 and KEYTRUDA for use in cases of non-small ...

RSV, which stands for respiratory syncytial ... thanks to ongoing clinical trials of new immunizations and treatments, including mRNA vaccines that would be given to mothers who would pass ...